Study on Subarachnoid Hemorrhage Care in Switzerland

Swiss Study on Subarachnoid Hemorrhage

Recruiting Observational Study
Subarachnoid Hemorrhage Intracranial Aneurysm
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
5,000 (estimated)
Sponsor
University Hospital, Geneva · Other
Who this trial is looking for

This trial is looking for patients who have been diagnosed with a certain type of brain bleeding called aneurysmal subarachnoid hemorrhage. Participants will contribute to a database that helps understand current treatment practices and patient outcomes in Switzerland.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with aneurysmal subarachnoid hemorrhage

You may not be able to join if

  • I have bleeding in my brain but no source can be found
  • My bleeding is caused by something other than a brain aneurysm

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This registry was created to assess management parameters of patients treated for aneurysmal subarachnoid hemorrhage in Switzerland. All Swiss hospitals with a neurosurgery department, an intensive care unit and an interventional neuroradiology team that treat neurovascular emergencies participate in the registry. Clinical parameters are entered into a common database. This database will provide (…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: \- Patients admitted with a proven diagnosis of aneurysmal subarachnoid hemorrhage. Exclusion criteria: \- Patients in whom the source of haemorrhage could not be identified (angiogram-negative SAH) or SAH with other causes than cerebral aneurysms.
Contacts

Karl Schaller, MD

+41223728202

karl.schaller@hcuge.ch

CONTACT

Philippe Bijlenga, MD PhD

+41792044043

philippe.bijlenga@hcuge.ch

CONTACT